![Metrion Biosciences 7 Metrion Biosciences Leaders in Ion Channel Sciences copy](https://www.metrionbiosciences.com/wp-content/uploads/2021/01/Metrion_Biosciences_Leaders_in_Ion_Channel_Sciences-copy.jpg)
![Metrion Biosciences 8 Metrion Icon 01](https://www.metrionbiosciences.com/wp-content/uploads/2021/03/Metrion_Icon-01-150x150.png)
Specialist preclinical drug discovery CRO
Ion channels • Cardiac safety • Neuroscience
Good Laboratory Practice (GLP) hERG screening service launched
Neuroscience service now includes CNS drug discovery
![Metrion Biosciences 9 Metrion Upcoming Events Background scaled](https://www.metrionbiosciences.com/wp-content/uploads/2021/03/Metrion_Upcoming_Events_Background-scaled.jpg)
Metrion Biosciences
Latest News
Metrion Biosciences appoints Dr Chris Mathes as Chief Commercial Officer
23rd July 2024
Metrion Biosciences Limited (“Metrion”), the specialist preclinical contract research organisation (CRO) and a leader in ion channel screening, today announced the appointment of Dr Chris Mathes, MBA, as Chief Commercial Officer (CCO). Chris will work alongside the Company’s expert leadership team to drive commercial strategy and lead global business development and marketing activities.
Metrion Biosciences enhances high-throughput screening services with access to Enamine compound libraries
11th April 2024
Metrion Biosciences Limited (“Metrion”), the specialist ion channel and cardiac safety screening contract research organisation (CRO) and drug discovery company, and Enamine Ltd (“Enamine”), the global leader in supplying small molecules and early drug discovery services, announced that Metrion has enhanced its High Throughput Screening (HTS) services with the addition of access to Enamine’s compound libraries.
- The path to my industrial placement at Metrion Biosciences: Beth Sharp
- Supporting an integrated QTc risk assessment using the hERG margin distributions for three positive control agents derived from multiple laboratories and on multiple occasions
- Industrial placement review: Molly Rowlett
- DisPATCHes newsletter Q2 2024
- Development and validation of a dual modality TREK-1 screening assay on the automated patch clamp Qube 384 platform
- Scientifica PatchScope Pro: an integrated calcium-imaging and patch-clamp system suitable for selecting specific subsets of neurons for electrophysiology recordings
![Metrion Biosciences 9 Metrion Upcoming Events Background scaled](https://www.metrionbiosciences.com/wp-content/uploads/2021/03/Metrion_Upcoming_Events_Background-scaled.jpg)
News and Upcoming Events
Read news including equity financing, launch of GLP hERG Screening service, key appointments, collaboration with KCNC1 Foundation, High-Throughput Screening, expansion of ion channel screening services.
For media enquiries please email us here.
We hold and participate in numerous events each year for professional development, knowledge sharing, self-improvement and networking opportunities.
Please schedule a meeting with us to discuss any questions or any specific ion channel and assay requirements. We look forward to meeting you shortly.
Receive the latest ion channel and cardiac safety news and insights to your inbox
Our quarterly newsletter is packed full of the latest Ion Channel news and reviews. We cover events, webinars, research findings, and publications and insights from our team, partners, and distinguished guests.
![Metrion Biosciences 17 Wave Background thinner 01 1](https://www.metrionbiosciences.com/wp-content/uploads/2021/01/Wave_Background_thinner-01-1.png)
Let’s work together
What are your specific ion channel and assay needs?
If you have any questions or would like to discuss your specific assay requirements, we will put you directly in touch with a member of our scientific team. Contact us today to discover more.